Literature DB >> 18475019

The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome.

Takahide Kohro1, Yuji Furui, Naohiro Mitsutake, Ryo Fujii, Hiroyuki Morita, Shinya Oku, Kazuhiko Ohe, Ryozo Nagai.   

Abstract

Similar to the healthcare systems in other industrialized countries, the Japanese healthcare system is facing the problem of increasing medical expenditure. In Japan, this situation may be primarily attributed to advanced technological developments, an aging population, and increasing patient demand. Japan also faces the problem of a declining youth population due to a low birth rate. Taken together, these problems present the healthcare system with a very difficult financial situation. Several reforms have been undertaken to contain medical expenditure, such as increasing employee copayment for health insurance from 10% to 20% in 1997 and from 20% to 30% in 2003 in order to curb unnecessary visits to medical institutions. Since the aging of the Japanese population is inevitable, a suitable method to contain medical expenditure may be to screen individuals who are likely to develop lifestyle-related diseases and conduct early intervention programs for them to prevent the development of diseases such as myocardial infarction or stroke that are costly to treat. If this goal is attained, it may contribute to the containment of medical expenditure as well as to improving the quality of life of the elderly. Therefore, the Japanese Ministry of Health, Labor and Welfare has decided to introduce a nationwide health screening and intervention program specifically targeting the metabolic syndrome commencing April 2008. Here, we discuss (1) the background of the Japanese healthcare system and the problems facing it, (2) the underlying objective and details of the new screening program, and (3) the expected impact of the program.

Entities:  

Mesh:

Year:  2008        PMID: 18475019     DOI: 10.1536/ihj.49.193

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  53 in total

1.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

2.  The accumulation of healthy lifestyle behaviors prevents the incidence of chronic kidney disease (CKD) in middle-aged and older males.

Authors:  Ryoma Michishita; Takuro Matsuda; Shotaro Kawakami; Akira Kiyonaga; Hiroaki Tanaka; Natsumi Morito; Yasuki Higaki
Journal:  Environ Health Prev Med       Date:  2016-01-21       Impact factor: 3.674

3.  Weight gain after 20 years of age is associated with prevalence of chronic kidney disease.

Authors:  Minako Wakasugi; Ichiei Narita; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Shoichi Fujimoto; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-11-26       Impact factor: 2.801

4.  Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations.

Authors:  Yuji Sato; Shouichi Fujimoto; Tsuneo Konta; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Kenjiro Kimura; Ichiei Narita; Masahide Kondo; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2014-11-30       Impact factor: 2.801

5.  The role of distubances of phosphate metabolism in metabolic syndrome.

Authors:  Marilena Stoian; Victor Stoica
Journal:  Maedica (Buchar)       Date:  2014-09

6.  Differences in the local and national prevalences of chronic kidney disease based on annual health check program data.

Authors:  Minako Wakasugi; Junichiro James Kazama; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2012-04-11       Impact factor: 2.801

7.  The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation.

Authors:  R K Simmons; K G M M Alberti; E A M Gale; S Colagiuri; J Tuomilehto; Q Qiao; A Ramachandran; N Tajima; I Brajkovich Mirchov; A Ben-Nakhi; G Reaven; B Hama Sambo; S Mendis; G Roglic
Journal:  Diabetologia       Date:  2009-12-11       Impact factor: 10.122

8.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial.

Authors:  Theresa M Marteau; Eleanor Mann; A Toby Prevost; Joana C Vasconcelos; Ian Kellar; Simon Sanderson; Michael Parker; Simon Griffin; Stephen Sutton; Ann Louise Kinmonth
Journal:  BMJ       Date:  2010-05-13

9.  Effects of Informal Caregivers' Health on Care Recipients.

Authors:  Michio Yuda; Jinkook Lee
Journal:  Jpn Econ Rev (Oxf)       Date:  2016-06-02

10.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.

Authors:  Eleanor Mann; A Toby Prevost; Simon Griffin; Ian Kellar; Stephen Sutton; Michael Parker; Simon Sanderson; Ann Louise Kinmonth; Theresa M Marteau
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.